WD repeat-containing protein: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
<StructureSection load='' size='340' side='right' caption='Human WD-repeat protein 5 (deepskyblue) complex with histone H3 peptide (magenta) (PDB code [[2h9m]])' scene='70/709459/Cv/1'> | <StructureSection load='' size='340' side='right' caption='Human WD-repeat protein 5 (deepskyblue) complex with histone H3 peptide (magenta) (PDB code [[2h9m]])' scene='70/709459/Cv/1'> | ||
== Function == | == Function == | ||
'''WD repeat-containing proteins''' (WDR) contain 4 or more repeating WD units. WD repeats are ca. 40 amino acid long usually bordered by Gly-His and Trp-Asp (WD). All WDRs form a β-propeller structure. WDRs have critical roles in many biological functions like signal transduction, transcription regulation and apoptosis<ref>PMID:11814058</ref>. <br /> | '''WD repeat-containing proteins''' or '''ribosome biogenesis protein WDR''' (WDR) contain 4 or more repeating WD units. WD repeats are ca. 40 amino acid long usually bordered by Gly-His and Trp-Asp (WD). All WDRs form a β-propeller structure. WDRs have critical roles in many biological functions like signal transduction, transcription regulation and apoptosis<ref>PMID:11814058</ref>. <br /> | ||
*'''WD-repeat protein 5''' (WDR5) contains 7 WD repeats. WDR5 contributes to histone modification. It may position the N-terminal of histone H3 for efficient methylation at Lys4. This methylation is implicated in the control of activation of cell lineage genes during embryogenesis. WDR5 interacts with histone-lysine N-methyltransferase (MLL)<ref>PMID:21531708</ref>. <br /> | *'''WD-repeat protein 5''' (WDR5) contains 7 WD repeats. WDR5 contributes to histone modification. It may position the N-terminal of histone H3 for efficient methylation at Lys4. This methylation is implicated in the control of activation of cell lineage genes during embryogenesis. WDR5 interacts with histone-lysine N-methyltransferase (MLL)<ref>PMID:21531708</ref>. <br /> | ||
*'''WD repeat-containing protein 48 and 20''' act as regulators of deubiquinating complexes. | *'''WD repeat-containing protein 48 and 20''' act as regulators of deubiquinating complexes. | ||
| Line 23: | Line 23: | ||
**[[3mxx]], [[3n0d]], [[3n0e]] – hWDR5 (mutant)<br /> | **[[3mxx]], [[3n0d]], [[3n0e]] – hWDR5 (mutant)<br /> | ||
**[[3smr]], [[3ur4]], [[4ia9]], [[4qqe]], [[4ql1]], [[5eal]], [[5eam]], [[5eap]], [[5ear]] – hWDR5 + piperazine derivative<br /> | **[[3smr]], [[3ur4]], [[4ia9]], [[4qqe]], [[4ql1]], [[5eal]], [[5eam]], [[5eap]], [[5ear]] – hWDR5 + piperazine derivative<br /> | ||
**[[6u5m]], [[6u5y]], [[6u6w]], [[6u80]], [[6u8b]], [[6u8l]], [[6u8o]] – hWDR5 + sulfonamide inhibitor<br /> | |||
**[[6ufx]], [[6ucs]], [[6pg3]], [[6pg4]], [[6pg5]], [[6pg6]], [[6pg7]], [[6pg8]], [[6pg9]], [[6pga]], [[6pgb]], [[6pgc]], [[6pgd]], [[6pge]], [[6pgf]], [[5vfc]], [[6dar]], [[6das]], [[6d9x]], [[6dai]], [[6dak]], [[6e1z]], [[6e1y]], [[6e22]], [[6e23]] – hWDR5 + inhibitor<br /> | |||
**[[2cnx]], [[2co0]], [[2h6k]], [[2h6n]], [[2h6q]], [[2h13]], [[2h9m]], [[2h9n]], [[2h9p]], [[2g99]], [[2g9a]], [[2o9k]], [[3psl]], [[4a7j]] – hWDR5 + histone H3 peptide<br /> | **[[2cnx]], [[2co0]], [[2h6k]], [[2h6n]], [[2h6q]], [[2h13]], [[2h9m]], [[2h9n]], [[2h9p]], [[2g99]], [[2g9a]], [[2o9k]], [[3psl]], [[4a7j]] – hWDR5 + histone H3 peptide<br /> | ||
**[[4gm3]], [[4gm8]], [[4gm9]], [[4gmb]] – hWDR5 + peptide inhibitor<br /> | **[[4gm3]], [[4gm8]], [[4gm9]], [[4gmb]] – hWDR5 + peptide inhibitor<br /> | ||
**[[2xl2]], [[2xl3]] – hWDR5 + retinoblastoma-binding protein 5 peptide<br /> | **[[2xl2]], [[2xl3]] – hWDR5 + retinoblastoma-binding protein 5 peptide<br /> | ||
| Line 33: | Line 34: | ||
**[[3eg6]], [[3emh]], [[3uvk]], [[3uvl]], [[3uvm]], [[3uvn]], [[3uvo]], [[4erq]], [[4ery]], [[4es0]], [[4esg]], [[4ewr]], [[5sxm]] – hWDR5 + MLL peptide<br /> | **[[3eg6]], [[3emh]], [[3uvk]], [[3uvl]], [[3uvm]], [[3uvn]], [[3uvo]], [[4erq]], [[4ery]], [[4es0]], [[4esg]], [[4ewr]], [[5sxm]] – hWDR5 + MLL peptide<br /> | ||
**[[4erz]] – hWDR5 + MLL4<br /> | **[[4erz]] – hWDR5 + MLL4<br /> | ||
**[[6kiv]], [[6kiz]], [[6kiu]], [[6kix]] – hWDR5 in MLL1-ubNCP complex - Cryo EM<br /> | |||
**[[6kiw]] – hWDR5 in MLL3-ubNCP complex - Cryo EM<br /> | |||
**[[6pww]], [[6pwv]] – hWDR5 + MLL1 + RbBP5 + histones - Cryo EM<br /> | |||
**[[6byn]] – hWDR5 + monobody<br /> | **[[6byn]] – hWDR5 + monobody<br /> | ||
**[[3p4f]] – hWDR5 + retinoblastoma-binding protein 5 peptide + MLL peptide<br /> | **[[3p4f]] – hWDR5 + retinoblastoma-binding protein 5 peptide + MLL peptide<br /> | ||
**[[6iam]] – hWDR5 + small ubiquitin-related modifier 5<br /> | |||
*WDR9 | *WDR9 | ||
**[[2q2e]] – hWDR9 residues 1310-1430<br /> | **[[2q2e]] – hWDR9 residues 1310-1430<br /> | ||
*WDR12 | |||
**[[6p0q]] – hWDR12 UBL domain residues 1-87<br /> | |||
**[[6n31]] – hWDR12 residues 90-422<br /> | |||
*WDR20 | *WDR20 | ||
**[[5k19]] – hWDR20<br /> | **[[5k19]] – hWDR20<br /> | ||
*WDR33 or pre-mRNA 3' end processing protein WDR33 | |||
**[[6f9n]] – hWDR33 residues 35-410 + CPSF160<br /> | |||
**[[6urg]] – hWDR33 + CPSF160 + CPSF30 + CPSF100 - Cryo EM<br /> | |||
**[[6fbs]], [[6fuw]], [[6uro]] – hWDR33 + CPSF160 + CPSF30 + PAS motif - Cryo EM<br /> | |||
*WDR48 | *WDR48 | ||
| Line 50: | Line 66: | ||
**[[5l8w]], [[5cvn]], [[5cvo]] – hWDR48 + ubiquitin + ubiquitin carboxyl-terminal hydrolase<br /> | **[[5l8w]], [[5cvn]], [[5cvo]] – hWDR48 + ubiquitin + ubiquitin carboxyl-terminal hydrolase<br /> | ||
**[[5k1a]], [[5k1b]] – hWDR48 + ubiquitin carboxyl-terminal hydrolase<br /> | **[[5k1a]], [[5k1b]] – hWDR48 + ubiquitin carboxyl-terminal hydrolase<br /> | ||
**[[5k1c]] – hWDR48 + WDR20 + ubiquitin carboxyl-terminal hydrolase<br /> | **[[5k1c]], [[6jlq]] – hWDR48 + WDR20 + ubiquitin carboxyl-terminal hydrolase<br /> | ||
*WDR60 | |||
**[[6rlb]], [[6sc2]] – hWDR60 + WDR34 + dynein + O6-alkylguanine-DNA alkyktransferase - Cryo EM<br /> | |||
*WDR61 | *WDR61 | ||
**[[3ow8]] – hWDR61<br /> | **[[3ow8]] – hWDR61<br /> | ||
*WDR91 | |||
**[[6vyc]] – hWDR91 residues 392-747<br /> | |||
*WDR92 | *WDR92 | ||
**[[ | **[[3i2n]] – hWDR92<br /> | ||
*WDR SLP1 | *WDR SLP1 | ||
Revision as of 09:38, 28 March 2020
| ||||||||||||
3D Structures of WD-repeat protein
Updated on 28-March-2020
References
Proteopedia Page Contributors and Editors (what is this?)
Michal Harel, Alexander Berchansky, Jaime Prilusky, Joel L. Sussman